...the submicron range are part of your production or...rol of particle size is important to you. You need...t populations in your sample every time. The N5 Su...tion Spectroscopy (PCS) , which determines particl...
...ndria Derived Activator of Caspase/DIABLO Liquid...THAW CYCLES. Amino acid residues 56 - 239 of human...® sequence was expressed in and purified from...ochrome c during apoptosis and promotes caspase ...
...as originally formulated to support the growth of ...,Antherea eucalypti. The medium is a modification ...hemolymph. The cell lines established by Grace usi...eloped. The basal medium, when properly supplement...
Vsp I from Promega
Biology Products:(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 ...olecular sensing and imaging devices which shed li...that it has signed exclusive distribution deals fo...nsors. The markets covered include Australia, New...enelux), Suriname, Italy, France, Spain, Portugal,...
(Date:11/4/2009)..., CARLSBAD, Calif., Oct. 23 GenVau...biosample management for genomic discovery, medici...Wellis, Ph.D., GenVault,s President and CEO, will ...king place on October 26th and 27th in La Jolla, C...provide an overview of the company together with r...
(Date:11/4/2009)..., SEATTLE, Nov. 4 Glencoe Software...Environment (OME) Consortium ( http://openmicrosc... with the American Society of Cell Biology,s excit...." The ASCB has been awarded a $2.5M stimulus gran...) Grand Opportunities program, as part of the Amer...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 1Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 3Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 4Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 5Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 1Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 2Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 1Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 2Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 3Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 4Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 5Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 6(Date:11/5/2009)...eb., Nov. 5 Transgenomic...financial results for the quarter ended September ...ented in the tables that follow. ,, Third Quar... $366,000 or $0.01 per share for the third quarter...$0.01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)... Calif., Nov. 5 WaferGen...ading developer of state-of-the-art genetic analys..., Ph.D. has joined the company,s Scientific Adviso...g and commercializing novel molecular diagnostics ...n the development of computational biology systems...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pr...EB) November 5, 2009 -- Professional Reprographics...ics company is pleased to present Brooke Sanders t...raphics/PR specialist. The addition of Brooke to t...wth within Professional Reprographics., , ,Brooke ...
(Date:11/4/2009)..., ROCKVILLE, Md., Nov. 4 Zyngenia,...cused on next-generation antibody drug development...in Series A funding from New Enterprise Associates... firms. The capital will be used to create novel, ...s two or more biological targets with a single age...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4